Abstract Submissions, Registration, and Hotel Reservations Now Open for WORLDSymposium™ 2027
More than 2,000 participants from over 50 countries will gather in San Diego, January 31–February 4, to advance
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
More than 2,000 participants from over 50 countries will gather in San Diego, January 31–February 4, to advance lysosomal and rare disease research.
MINNEAPOLIS, MN, UNITED STATES, August 13, 2026 /EINPresswire.com/ — WORLDSymposium™ has opened abstract submissions, award nominations, attendee registration, and hotel reservations for the 23rd Annual WORLDSymposium, taking place January 31–February 4, 2027, at the Manchester Grand Hyatt in San Diego, California.
As the largest international scientific meeting focused on lysosomal and related rare diseases, WORLDSymposium brings together more than 2,000 researchers, clinicians, patient advocates, regulatory professionals, and industry leaders from over 50 countries.
“WORLDSymposium provides a unique forum to connect and collaborate with global leaders in lysosomal disease research and treatment. There is no other scientific or research meeting like it.”
— Uma Ramaswami, FRCPCH, MD, Royal Free London NHS Foundation Trust, University College London, United Kingdom
Since its founding in 2004, WORLDSymposium has evolved from a focused gathering of lysosomal disease researchers into a comprehensive, cross-disciplinary forum connecting basic science, translational research, clinical applications, regulatory strategy, and industry development. The annual scientific program examines the challenges involved in translating lysosomal disease research from laboratory discovery to human therapy.
Abstract Submissions Open Through October 1
The abstract submission portal is open through October 1, 2026, at 17:00 CDT. Abstracts received by the deadline will be reviewed by the WORLDSymposium Scientific Committee for potential platform or poster presentation. Notifications will be issued by November 2, 2026.
A separate Late-Breaking Abstract category will be available November 1–December 1, 2026, for investigators with new and impactful data that was not available by the primary submission deadline.
“All of the global lysosomal disease researchers, clinicians, advocates, and partners connect at WORLDSymposium. Not only does WORLDSymposium provide the latest groundbreaking lysosomal disease research, it also provides a comprehensive forum to meet and collaborate with the leaders who are changing the future of lysosomal and rare diseases. It is the one annual scientific meeting that I never miss.”
— Professor Roberto Giugliani, MD, PhD, Professor of Genetics, Federal University of Rio Grande do Sul, and Executive Director of Casa dos Raros, Porto Alegre, Brazil
Award Nominations Open Through September 1
Nominations for the 2027 WORLDSymposium Awards are open through September 1, 2026. The annual Roscoe O. Brady Award, Patient Advocate Leader Award, New Treatment Award, and Catalyst Award recognize achievement in scientific innovation, advocacy, therapeutic development, and emerging leadership.
Registration and Hotel Reservations
General registration is now open at worldsymposia.org. Attendees are encouraged to register early and reserve accommodations within the official room block at the Manchester Grand Hyatt. Rooms are available on a first-come, first-served basis and are expected to fill quickly.
About WORLDSymposium
WORLDSymposium™ (We’re Organizing Research on Lysosomal Diseases) is an annual global medical education conference focused on lysosomal and related diseases. Now in its 23rd year, the meeting brings together more than 2,000 researchers, clinicians, patient advocates, and industry professionals from over 50 countries to exchange knowledge and advance the field. The 2027 Annual Scientific Meeting will take place January 31–February 4, 2027, at the Manchester Grand Hyatt in San Diego, California. The scientific program is led by WORLDSymposium founder and Course Director Chester B. Whitley, PhD, MD, and jointly managed by Etherio and Saterdalen & Associates, LLC.
Sarah Jansen
WORLDSymposium c/o Etherio Group
worldsymposia@etherio.com
Visit us on social media:
LinkedIn
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery

